This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Arquivos Brasileiros de Endocrinologia & Metabologia | |
|---|---|
| Title | Arquivos Brasileiros de Endocrinologia & Metabologia |
| Discipline | Endocrinology |
| Language | Portuguese, English |
| Abbreviation | Arq. Bras. Endocrinol. Metab. |
| Publisher | Sociedade Brasileira de Endocrinologia e Metabologia |
| Country | Brazil |
| History | 1951–present |
| Frequency | Bimonthly |
| Issn | 0004-2730 |
Arquivos Brasileiros de Endocrinologia & Metabologia is a peer-reviewed medical journal founded in the mid-20th century focusing on clinical and basic research in endocrinology and metabolism. The journal has served as a regional platform connecting researchers from institutions such as Universidade de São Paulo, Universidade Federal do Rio de Janeiro, Fundação Oswaldo Cruz, Universidade Estadual de Campinas and international centers like Harvard Medical School, Johns Hopkins University, Mayo Clinic and Imperial College London. Its readership spans clinicians, researchers and policy stakeholders affiliated with organizations including World Health Organization, Pan American Health Organization, National Institutes of Health and European Society of Endocrinology.
The journal was established during a period of institutional consolidation when entities such as Associação Médica Brasileira, Academia Nacional de Medicina and regional medical societies increased scholarly output, joining networks that included Sociedade Brasileira de Diabetes and Associação Brasileira de Nutrição. Early editorial leadership featured figures tied to Universidade Federal do Rio Grande do Sul, Universidade Federal de Minas Gerais, Hospital das Clínicas da Faculdade de Medicina da USP and influencing research agendas alongside international collaborators from Karolinska Institutet, University of Oxford, University of Cambridge, Université Paris-Saclay and Max Planck Society. Throughout decades, the journal reflected shifts driven by guidelines from American Diabetes Association, Endocrine Society, International Diabetes Federation, and multicenter trials coordinated with groups such as Diabetes Control and Complications Trial contributors and investigators linked to Framingham Heart Study methodologies. Institutional milestones paralleled national science policy changes involving CNPq, CAPES, FAPESP and partnerships with agencies like Wellcome Trust, Bill & Melinda Gates Foundation and European Commission research frameworks.
The journal's remit covers clinical endocrinology linked to institutions such as Hospital Israelita Albert Einstein, Hospital das Clínicas de Ribeirão Preto, Instituto do Coração, and basic science from laboratories at Instituto Butantan, Instituto de Biofísica Carlos Chagas Filho, Instituto de Química da USP, and international centers including Salk Institute, Cold Spring Harbor Laboratory and Broad Institute. Topics often intersect with specialty societies like Sociedade Brasileira de Endocrinologia e Metabologia, International Society of Endocrinology, European Association for the Study of Diabetes, American Association of Clinical Endocrinologists, and clinical trial networks exemplified by REdetec-style collaborations. Research domains include diabetes mellitus research modeled after UK Prospective Diabetes Study, thyroid disorders referenced against American Thyroid Association guidance, adrenal disease investigations resonant with European Society of Endocrinology protocols, and metabolic bone disease studies informed by International Osteoporosis Foundation recommendations.
The editorial board has included editors affiliated with Universidade Federal do Ceará, Universidade Federal do Paraná, Universidade de Brasília, Hospital Universitário Clementino Fraga Filho and guest editors from Stanford University School of Medicine, Yale School of Medicine, University of California, San Francisco, Columbia University Irving Medical Center and University of Toronto. The journal uses peer review practices compatible with standards from COPE-influenced frameworks and reporting guidance aligned with STROBE, CONSORT, PRISMA and ARRIVE where applicable. Production workflows interface with indexing services administered by Scopus, Web of Science Group, PubMed Central and repository initiatives like SciELO and LILACS. Funding acknowledgements commonly cite support from FAPEMIG, PWD Research Foundation, National Science Foundation collaborations and multinational grants coordinated with Horizon 2020 partners.
The journal is abstracted and indexed in databases and services including Index Medicus, MEDLINE, Embase, Scopus, Web of Science, PubMed, SciELO, LILACS, DOAJ and specialist registries used by organizations such as National Library of Medicine, Clarivate Analytics and Elsevier. Citation metrics are tracked by platforms like Google Scholar, CrossRef, Dimensions and Altmetric, and bibliometric analyses reference benchmarking conducted by SciVal and national evaluations overseen by CAPES.
Notable articles published in the journal have reported epidemiological data from cohorts connected to Projeto SP REGIÃO METROPOLITANA, regional diabetes registries linked to Sociedade Brasileira de Diabetes, genetic studies involving collaborations with Human Genome Project-era investigators, and public health analyses citing directives from Ministério da Saúde (Brazil), Secretaria de Estado da Saúde de São Paulo and municipal health departments. Influential reviews have drawn on comparative guidelines from American Diabetes Association, European Society of Cardiology, Endocrine Society and clinical outcome research paralleling landmark trials such as UK Prospective Diabetes Study and ADVANCE Trial. The journal's impact is evident in citations by authors at Universidade de Chile, Universidad Nacional Autónoma de México, Pontificia Universidad Católica de Chile, Johns Hopkins University, Mayo Clinic and policy documents of Pan American Health Organization.
Articles are available through platforms such as SciELO, institutional repositories of Universidade de São Paulo and national archives like Biblioteca Nacional do Brasil, with open access provisions consistent with funder mandates from Wellcome Trust, Bill & Melinda Gates Foundation and national agencies like CNPq. Subscriptions and institutional access involve consortia negotiations with libraries at Universidade Federal do Rio Grande do Sul, Universidade Federal de Santa Catarina and international agreements with academic consortia including Research4Life and INASP. Archival content is preserved in digital repositories corporating standards from LOCKSS, CLOCKSS and national preservation initiatives coordinated with Biblioteca Nacional do Brasil.
Category:Endocrinology journals Category:Medical journals published in Brazil